Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Astrazeneca PLC (NASDAQ: AZN) rose significantly recently. AZN’s current Value Trend Rating is C and the prior Rating was F. Details supporting this higher rating are included in our next report.
Recent Price Action
On 3/14/25, Astrazeneca PLC (NASDAQ: AZN) stock increased 1.4%, closing at $77.60. This advance was accompanied by normal trading volume. Relative to the market the stock has been weak over the last nine months but is unchanged during the last week.
Current PriceTarget Research Rating
Astrazeneca has a current Value Trend Rating of C (Low Neutral). This VT Rating rose significantly in recent days from F previously. The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Astrazeneca has a good Appreciation Score of 84 but a very low Power Rating of 13, triggering the Low Neutral Value Trend Rating.
Be the first to comment